Cargando…

ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer

BACKGROUND: Current studies on the role of ARHGAP39 mainly focused on its effect on neurodevelopment. However, there are few studies on the comprehensive analysis of ARHGAP39 in breast cancer. METHODS: ARHGAP39 expression level was analyzed based on the Cancer Genome Atlas (TCGA), the Genotype-Tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Litong, Li, Yuwei, Li, Siyuan, Wang, Mozhi, Cao, Hongyi, Xu, Ling, Xu, Yingying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184379/ https://www.ncbi.nlm.nih.gov/pubmed/37189064 http://dx.doi.org/10.1186/s12885-023-10904-4

Ejemplares similares

ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Fan, Biao, et al.
Publicado: (2021)

Biological function analysis of ARHGAP39 as an independent prognostic biomarker in hepatocellular carcinoma
por: Ding, Yongqi, et al.
Publicado: (2023)

Predictive and Prognostic Roles of Pathological Indicators for Patients with Breast Cancer on Neoadjuvant Chemotherapy
por: Li, Xinyan, et al.
Publicado: (2019)

Transcriptomic Analysis Identified ARHGAP Family as a Novel Biomarker Associated With Tumor-Promoting Immune Infiltration and Nanomechanical Characteristics in Bladder Cancer
por: Yang, Chen, et al.
Publicado: (2021)

KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer
por: Yao, Litong, et al.
Publicado: (2023)

Porf-2 = Arhgap39 = Vilse: A Pivotal Role in Neurodevelopment, Learning and Memory
por: Nowak, Felicia V.
Publicado: (2018)

A novel tumor suppressing gene, ARHGAP9, is an independent prognostic biomarker for bladder cancer
por: Piao, Xuan-Mei, et al.
Publicado: (2020)

Paxillin is a potential prognostic biomarker associated with immune cell infiltration in ovarian cancer
por: Meng, Li-qun, et al.
Publicado: (2023)

Pan‑cancer analysis identified ARHGAP23 as a potential biomarker for pancreatic adenocarcinoma
por: Liu, Xiaolong, et al.
Publicado: (2023)

HNRNPL Circularizes ARHGAP35 to Produce an Oncogenic Protein
por: Li, Yan, et al.
Publicado: (2021)

DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
por: Yuan, Mengping, et al.
Publicado: (2022)

An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine
por: Wang, Mozhi, et al.
Publicado: (2021)

DNA methylation of ARHGAP30 is negatively associated with ARHGAP30 expression in lung adenocarcinoma, which reduces tumor immunity and is detrimental to patient survival
por: Hu, Sheng, et al.
Publicado: (2021)

SNHG10 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Prostate Cancer
por: Chen, Qiang, et al.
Publicado: (2021)

Protooncogenic Role of ARHGAP11A and ARHGAP11B in Invasive Ductal Carcinoma: Two Promising Breast Cancer Biomarkers
por: Naeimzadeh, Y., et al.
Publicado: (2023)

Prognostic biomarker SYK and its correlation with immune infiltrates in glioma
por: Wang, Changxin, et al.
Publicado: (2023)

ARHGAP21 Is Involved in the Carcinogenic Mechanism of Cholangiocarcinoma: A Study Based on Bioinformatic Analyses and Experimental Validation
por: Wang, Zhihuai, et al.
Publicado: (2023)

Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study
por: Yao, Litong, et al.
Publicado: (2023)

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

Exploring the Metabolic Vulnerabilities of Epithelial–Mesenchymal Transition in Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma
por: Zhang, Yao-Hua, et al.
Publicado: (2022)

BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma
por: Chen, Yi-Ru, et al.
Publicado: (2020)

DCK is an Unfavorable Prognostic Biomarker and Correlated With Immune Infiltrates in Liver Cancer
por: Hu, Shu Fang, et al.
Publicado: (2020)

Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
por: Li, Xinyan, et al.
Publicado: (2020)

Can ACEI/ARB prevent the cardiotoxicity caused by chemotherapy in early-stage breast cancer?—a meta-analysis of randomized controlled trials
por: Dong, Haoran, et al.
Publicado: (2020)

S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer
por: Chen, Yuan, et al.
Publicado: (2021)

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

YKL-39 is an independent prognostic factor in gastric adenocarcinoma and is associated with tumor-associated macrophage infiltration and angiogenesis
por: Xue, Ling, et al.
Publicado: (2022)

Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation
por: Zhang, Hengjun, et al.
Publicado: (2023)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

ARHGAP25 expression in colorectal cancer as a biomarker associated with favorable prognosis
por: Zhang, Yue, et al.
Publicado: (2022)

CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Dan, et al.
Publicado: (2023)

IFI30 as a prognostic biomarker and correlation with immune infiltrates in glioma
por: Jiang, Wei, et al.
Publicado: (2021)

Integrated analysis of immune infiltration in esophageal carcinoma as prognostic biomarkers
por: Yin, Hang, et al.
Publicado: (2021)

PCOLCE Is Potent Prognostic Biomarker and Associates With Immune Infiltration in Gastric Cancer
por: Xiang, Aizhai, et al.
Publicado: (2020)

PODN is a prognostic biomarker and correlated with immune infiltrates in osteosarcoma
por: Yao, Feng, et al.
Publicado: (2021)

Role of Proton-Coupled Monocarboxylate Transporters in Cancer: From Metabolic Crosstalk to Therapeutic Potential
por: Sun, Xiangyu, et al.
Publicado: (2020)

HIF-1-induced mitochondrial ribosome protein L52: a mechanism for breast cancer cellular adaptation and metastatic initiation in response to hypoxia
por: Li, Xinyan, et al.
Publicado: (2021)

MELK is a prognostic biomarker and correlated with immune infiltration in glioma
por: Yang, Haiyan, et al.
Publicado: (2022)

ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer
por: Zhang, Junchang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tjjjq7jptjhu1596logoj70tc